Pulsed Radiofrequency of Suprascapular Nerve and Shoulder Joint for Chronic Shoulder Pain
Launched by SATASAIRAALA · Jan 30, 2021
Trial Information
Current as of June 26, 2025
Unknown status
Keywords
ClinConnect Summary
Introduction After spinal and knee pain, shoulder pain is estimated to be the third most common type of musculoskeletal pain, causing considerable psychosocial impact if progressing to the chronic phase. While majority of patients with shoulder pain recover within few months, over 40% of patients have persisting symptoms after 12 months. Establishing a treatment strategy for shoulder pain can be challenging, as the effectiveness of many treatment options is unclear. Non-surgical strategies are preferred in the first-line management, with physiotherapy being of the treatment of choice in the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • shoulder joint pain \>3 moths
- Exclusion Criteria:
- • Other ethiology as cervical root leasion or cancer.-
About Satasairaala
Satasairaala is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong focus on patient-centered care, Satasairaala collaborates with multidisciplinary teams to conduct rigorous studies across various therapeutic areas. The institution is committed to adhering to the highest ethical standards and regulatory guidelines while fostering an environment of scientific excellence. Through its comprehensive approach, Satasairaala aims to contribute significantly to the development of new treatments and therapies that enhance the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pori, , Finland
Patients applied
Trial Officials
hannu v heikkilä
Study Director
Satasairaala
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials